Uncategorized
Novartis announces Alcon Q3 net sales of $2.7 billion
Alcon’s earnings for the third quarter of 2014 included a 5% increase in net sales to $2.7 billion, with strong growth in surgical and moderate growth in vision care and ophthalmic pharmaceuticals, according to a press release from Novartis.An 8% increase in surgical growth was attributed primarily to strong sales for the Centurion phacoemulsification cataract platform and the LenSx femtosecond laser platform.